BioSyent (CVE:RX) Director Seyed Ahmad Ashrafi Sells 1,884 Shares of Stock

BioSyent Inc. (CVE:RX) Director Seyed Ahmad Ashrafi sold 1,884 shares of the stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of C$14.65, for a total transaction of C$27,600.60. Following the transaction, the director directly owned 37,261 shares in the company, valued at approximately C$545,873.65. This represents a 4.81% decrease in their ownership of the stock.

Seyed Ahmad Ashrafi also recently made the following trade(s):

• On Tuesday, June 30th, Seyed Ahmad Ashrafi sold 800 shares of BioSyent stock. The shares were sold at an average price of C$14.70, for a total transaction of C$11,760.00.
• On Tuesday, June 30th, Seyed Ahmad Ashrafi sold 600 shares of BioSyent stock. The stock was sold at an average price of C$14.50, for a total transaction of C$8,700.00.

BioSyent Stock Down 0.8%

Shares of RX traded down C$0.12 on Friday, reaching C$14.60. The company’s stock had a trading volume of 4,970 shares, compared to its average volume of 6,645. BioSyent Inc. has a twelve month low of C$10.65 and a twelve month high of C$15.80. The stock has a market capitalization of C$165.45 million, a PE ratio of 18.62 and a beta of 0.99. The company has a current ratio of 1.89, a quick ratio of 6.91 and a debt-to-equity ratio of 11.66. The firm has a fifty day moving average of C$14.20 and a 200-day moving average of C$14.22.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis.